Table of Contents

Global Atopic Dermatitis Therapeutics Market Growth (Status and Outlook) 2019-2024

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Atopic Dermatitis Therapeutics Market Size 2014-2024
  • 2.1.2 Atopic Dermatitis Therapeutics Market Size CAGR by Region
• 2.2 Atopic Dermatitis Therapeutics Segment by Type
  • 2.2.1 Topical Agents
  • 2.2.2 Topical Agents
• 2.3 Atopic Dermatitis Therapeutics Market Size by Type
  • 2.3.1 Global Atopic Dermatitis Therapeutics Market Size Market Share by Type (2014-2019)
  • 2.3.2 Global Atopic Dermatitis Therapeutics Market Size Growth Rate by Type (2014-2019)
• 2.4 Atopic Dermatitis Therapeutics Segment by Application
  • 2.4.1 Adult
  • 2.4.2 Child
• 2.5 Atopic Dermatitis Therapeutics Market Size by Application
  • 2.5.1 Global Atopic Dermatitis Therapeutics Market Size Market Share by Application (2014-2019)
  • 2.5.2 Global Atopic Dermatitis Therapeutics Market Size Growth Rate by Application (2014-2019)

3 Global Atopic Dermatitis Therapeutics by Players

• 3.1 Global Atopic Dermatitis Therapeutics Market Size Market Share by Players
  • 3.1.1 Global Atopic Dermatitis Therapeutics Market Size by Players (2017-2019)
  • 3.1.2 Global Atopic Dermatitis Therapeutics Market Size Market Share by Players (2017-2019)
• 3.2 Global Atopic Dermatitis Therapeutics Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Atopic Dermatitis Therapeutics by Regions

• 4.1 Atopic Dermatitis Therapeutics Market Size by Regions
• 4.2 Americas Atopic Dermatitis Therapeutics Market Size Growth
• 4.3 APAC Atopic Dermatitis Therapeutics Market Size Growth
• 4.4 Europe Atopic Dermatitis Therapeutics Market Size Growth
• 4.5 Middle East & Africa Atopic Dermatitis Therapeutics Market Size Growth

5 Americas

• 5.1 Americas Atopic Dermatitis Therapeutics Market Size by Countries
• 5.2 Americas Atopic Dermatitis Therapeutics Market Size by Type
• 5.3 Americas Atopic Dermatitis Therapeutics Market Size by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Atopic Dermatitis Therapeutics Market Size by Countries
• 6.2 APAC Atopic Dermatitis Therapeutics Market Size by Type
• 6.3 APAC Atopic Dermatitis Therapeutics Market Size by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Atopic Dermatitis Therapeutics by Countries
• 7.2 Europe Atopic Dermatitis Therapeutics Market Size by Type
• 7.3 Europe Atopic Dermatitis Therapeutics Market Size by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Atopic Dermatitis Therapeutics by Countries
• 8.2 Middle East & Africa Atopic Dermatitis Therapeutics Market Size by Type
• 8.3 Middle East & Africa Atopic Dermatitis Therapeutics Market Size by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Atopic Dermatitis Therapeutics Market Forecast

• 10.1 Global Atopic Dermatitis Therapeutics Market Size Forecast (2019-2024)
• 10.2 Global Atopic Dermatitis Therapeutics Forecast by Regions
  • 10.2.1 Global Atopic Dermatitis Therapeutics Forecast by Regions (2019-2024)
  • 10.2.2 Americas Market Forecast
  • 10.2.3 APAC Market Forecast
  • 10.2.4 Europe Market Forecast
  • 10.2.5 Middle East & Africa Market Forecast
• 10.3 Americas Forecast by Countries
  • 10.3.1 United States Market Forecast
  • 10.3.2 Canada Market Forecast
  • 10.3.3 Mexico Market Forecast
  • 10.3.4 Brazil Market Forecast
• 10.4 APAC Forecast by Countries
  • 10.4.1 China Market Forecast
  • 10.4.2 Japan Market Forecast
  • 10.4.3 Korea Market Forecast
  • 10.4.4 Southeast Asia Market Forecast
  • 10.4.5 India Market Forecast
  • 10.4.6 Australia Market Forecast
• 10.5 Europe Forecast by Countries
  • 10.5.1 Germany Market Forecast
  • 10.5.2 France Market Forecast
  • 10.5.3 UK Market Forecast
  • 10.5.4 Italy Market Forecast
  • 10.5.5 Russia Market Forecast
  • 10.5.6 Spain Market Forecast
• 10.6 Middle East & Africa Forecast by Countries
  • 10.6.1 Egypt Market Forecast
  • 10.6.2 South Africa Market Forecast
  • 10.6.3 Israel Market Forecast
  • 10.6.4 Turkey Market Forecast
  • 10.6.5 GCC Countries Market Forecast
• 10.7 Global Atopic Dermatitis Therapeutics Forecast by Type
• 10.8 Global Atopic Dermatitis Therapeutics Forecast by Application

11 Key Players Analysis

• 11.1 Pfizer
  • 11.1.1 Company Details
  • 11.1.2 Atopic Dermatitis Therapeutics Product Offered
  • 11.1.3 Pfizer Atopic Dermatitis Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
  • 11.1.4 Main Business Overview
  • 11.1.5 Pfizer News
• 11.2 Astellas
  • 11.2.1 Company Details
  • 11.2.2 Atopic Dermatitis Therapeutics Product Offered
  • 11.2.3 Astellas Atopic Dermatitis Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
  • 11.2.4 Main Business Overview
  • 11.2.5 Astellas News
• 11.3 Sanofi
  • 11.3.1 Company Details
  • 11.3.2 Atopic Dermatitis Therapeutics Product Offered
  • 11.3.3 Sanofi Atopic Dermatitis Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
  • 11.3.4 Main Business Overview
  • 11.3.5 Sanofi News
• 11.4 Novartis
  • 11.4.1 Company Details
  • 11.4.2 Atopic Dermatitis Therapeutics Product Offered
  • 11.4.3 Novartis Atopic Dermatitis Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
  • 11.4.4 Main Business Overview
  • 11.4.5 Novartis News

...

12 Research Findings and Conclusion

According to this study, over the next five years the Atopic Dermatitis Therapeutics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Atopic Dermatitis Therapeutics business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Atopic Dermatitis Therapeutics market by product type, application, key companies and key regions.

This study considers the Atopic Dermatitis Therapeutics value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Topical Agents
Systemic Therapies

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Adult
Child

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Astellas
Sanofi
Novartis
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Atopic Dermatitis Therapeutics market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Atopic Dermatitis Therapeutics market by identifying its various subsegments.
Focuses on the key global Atopic Dermatitis Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Atopic Dermatitis Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Atopic Dermatitis Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.